Clinical trial
Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients…
NCT00375791 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00375791 |
|---|---|
| Title | Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma |
| Official title | An Open-Label Phase II Study of the Safety and Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Relapsed or Relapsed/Refractory Multiple Myeloma |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | perifosine, dexamethasone |
| Enrollment | 67 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Oct 1, 2011 |
| First posted | Sep 13, 2006 |
| Last update posted | Feb 28, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: